Crossmark

Severe atopic dermatitis: Dupilumab is not just safer, but more efficient

Crossref DOI link: https://doi.org/10.1016/j.aller.2019.12.005

Published Print: 2020-11

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Giavina-Bianchi, Mara http://orcid.org/0000-0001-7059-4068
Rizzo, Luiz Vicente

Giavina-Bianchi, Pedro
License Information

Text and Data Mining valid from 2020-11-01
More Information

This article is maintained by: Elsevier

Article Title: Severe atopic dermatitis: Dupilumab is not just safer, but more efficient

Journal Title: Allergologia et Immunopathologia

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.aller.2019.12.005

Content Type: article

Copyright: © 2020 SEICAP. Published by Elsevier España, S.L.U. All rights reserved.